Sector portfolio · VC firm · United States

InterWest Partners' Biotech portfolio

InterWest Partners has backed 21 Biotech startups in rounds we track, $3.0B between them, shown by the stage each has reached. The best-funded is Cidara Therapeutics.

21startups backed
5stages
$3.0Braised between them
Series C and laterbiggest stage

InterWest Partners's whole portfolioInterWest Partners's profile

Segment by segment

Series C and later

9 startups · $1.4B raised

  1. CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M
  2. WelltokSilverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement.United States$239M
  3. AvedroAvedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.United States$203M
  4. ReVision OpticsReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process.United States$172M
  5. NeuroneticsNeuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.United States$110M
  6. Sera PrognosticsSera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.United States$107M
  7. Integrated DiagnosticsIntegrated Diagnostics develops tools to help physicians diagnose complex diseases with a non-invasive blood test.United States$95M
  8. CCentrexionUnited States$90M

Stage not reported

4 startups · $415M raised

  1. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M
  2. NeuroPaceNeuroPace develops and markets implantable devices for the treatment of neurological disorders.United States$141M
  3. CCebixCebix is a biopharmaceutical company focused on the treatment of diabetic complications.United States$96M
  4. GGobiquityUnited States$6.0M

Series B

3 startups · $688M raised

  1. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  2. Cardiac DimensionsCardiac Dimensions is a medical device company based in Kirkland, Washington, founded in 2001.United States$150M
  3. LyceraLycera discovers and develops small-molecule immunomodulators for the treatment of autoimmune diseases and cancer.United States$75M

Series A

3 startups · $88M raised

  1. LBLabrys BiologicsLabrys Biologics develops treatments for chronic migraine.-$46M
  2. Sequel PharmaceuticalsSequel Pharmaceuticals develops and commercializes novel and clinical-stage drug candidates for patients with cardiovascular disease.United States$25M
  3. Arcion TherapeuticsArcion Therapeutics is a biotechnology company developing treatments for chronic pain.United States$17M

Growth

2 startups · $352M raised

  1. GynesonicsGynesonics develops transcervical, uterus-preserving, incision-less technologies for diagnostic and therapeutic applications.United States$214M
  2. Alvine PharmaceuticalsAlvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.United States$138M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names InterWest Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like InterWest Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.